How to Buy Cyclerion Therapeutics Stock

Cyclerion Therapeutics Inc

Cyclerion Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases.

Cyclerion Therapeutics stock last closed at $2.99, up 10.74% from the previous day, and has decreased 1.97% in one year. It has overperformed other stocks in the Biotechnology industry by 0.75 percentage points. Cyclerion Therapeutics stock is currently +135.43% from its 52-week low of $1.27, and -68.43% from its 52-week high of $9.47.

There are currently 2.71M CYCN shares outstanding. The market capitalization of CYCN is $8.10M. In the past 24 hours, 20,097 CYCN shares were traded.

How to Buy Cyclerion Therapeutics Stock

Wondering how to invest in Cyclerion Therapeutics stock? Here's how.

  1. Choose where to buy Cyclerion Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Cyclerion Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your brokerage account: Choose your payment method and add your info.
  4. Evaluate Cyclerion Therapeutics stock: The Cyclerion Therapeutics ticker symbol is CYCN. Is Cyclerion Therapeutics stock a good investment? Should you buy shares of CYCN? How do CYCN's underlying business fundamentals look? Do top analysts think Cyclerion Therapeutics is a good buy? Why has CYCN's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if CYCN is a good stock to buy).
  5. Place your CYCN trade: Decide if you will purchase CYCN shares at the current market price or use a limit order to purchase CYCN stock at a particular price.
  6. Get the latest scoop on your investment in CYCN: Create a watchlist to track your position in Cyclerion Therapeutics stock.

Step 1: Choose where to buy Cyclerion Therapeutics stock

You will need an online brokerage account to access the NASDAQ market and buy CYCN stock.

A brokerage account enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've selected your brokerage, it's time to fill out some personal info so you are able to buy CYCN stock today.

How to Set Up a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to start your new trading account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have finished signing up on our top ranked stock app, you can securely and quickly fund your account:

Watch the walkthrough below to see the process of depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Cyclerion Therapeutics stock

Once you have identified the best place to buy Cyclerion Therapeutics stock, it's crucial to research their stock before you buy, so you actually understand the risk as well as the opportunity.

Cyclerion Therapeutics Metrics

CYCN Price
$2.99
1w %
11.15%
1y %
-1.97%
5y %
-95.72%
P/E
-2.47x
P/B
0.92x
P/S
3.77x
PEG
N/A
Revenue
$2.00M
Earnings
-$3.06M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$8.10M
Next Earnings
May 5, 2025
Next Dividend
N/A

Fundamentals of CYCN

WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on CYCN's stock page.

Is CYCN stock undervalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CYCN's intrinsic value.

Using relative valuations methods:

  • CYCN could be undervalued based on its P/B ratio of 0.92x, relative to Biotechnology industry P/B ratio of 4.16x

You can access more valuation research on CYCN's stock here.

A quick look at CYCN Financials

Passed Financial Due Diligence Checks:

  • There are more short-term assets than long-term liabilities on the CYCN balance sheet.
  • There are more short-term assets than short-term liabilities on the CYCN balance sheet.
  • CYCN has a low debt to equity ratio of 0.08.
  • CYCN has $3.23M in cash and short term investments. This is sufficient to cover its annual cash burn of $4.33M.
  • Total CYCN debt is lower than 5 years ago, relative to shareholder equity.

Failed Financial Due Diligence Checks:

  • CYCN has cash burn of 4333000. It does not have enough cash and short-term investments to cover this.
  • CYCN profit margin has gone down from N/A to -152.8% in the past year.

CYCN Technical Indicators

SMA10
2.68
SMA20
2.62
SMA50
2.71
SMA100
2.99
SMA200
2.89
MACD
0.02
MACD Signal
-0.02
MACD Histogram
0.05
RSI
61.7
Stochastic %K
76.67
Stochastic %D
66.67
StochRSI %K
76.34
StochRSI %D
66.17

CYCN Earnings

Last year, CYCN revenue was $2.00M. Over the last 5 year, CYCN's revenue has grown by -15% per year. This was slower than the Biotechnology industry average of 44.4%.

You can research CYCN's earnings and revenue performance here.

Are CYCN executives and large shareholders buying or selling the stock?

In the past 12 months, executives and large shareholders at CYCN have sold more shares than they have bought.

Peter M. Hecht, Director of CYCN, was the latest CYCN insider to buy. They bought $499,999.50 worth of CYCN shares on Mar 25, 2025.

Get more info about who owns CYCN stock here.

Can I get consistent income from CYCN stock?

No, Cyclerion Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about CYCN?

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Place your CYCN trade

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific price limit, use a limit order.

Hit the Open button and your broker will place your order.

If you want additional info about buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get the latest scoop on your investment in CYCN

Now that you own some shares in CYCN, you'll want to stay up-to-date on your investment.

Add CYCN to a watchlist to get the latest updates about your CYCN stock.

CYCN Feed

How to Buy Stock in Cyclerion Therapeutics

To reiterate, here are the 6 steps to buy Cyclerion Therapeutics stock:

  1. Choose where to buy Cyclerion Therapeutics stock
  2. Open a brokerage account
  3. Put funds into your brokerage account
  4. Evaluate Cyclerion Therapeutics stock
  5. Place your CYCN trade
  6. Get the latest scoop on your investment in CYCN

If you need a brokerage account, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your new investment in Cyclerion Therapeutics, create a watchlist today.

NASDAQ: CYCN
$2.99+0.29 (+10.74%)
Updated Apr 22, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CYCN
$2.99+0.29 (+10.74%)
Updated Apr 22, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Cyclerion Therapeutics share?

As of Apr 22, 2025, it costs $2.99 to buy one share of Cyclerion Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.334 shares of CYCN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Cyclerion Therapeutics stock?

One way to place an order for Cyclerion Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.